Sander Pajusalu

23PUBLICATIONS
132CO-AUTHORS
Disease surveillanceCancer geneticsEpidemiological methodsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 26, 2026
Population-Based Study of Drug-Resistant Epilepsy Before Age Two: Predominance of Developmental and Epileptic Encephalopathies.

|May 18, 2026
Exploring the somatic mutational landscape of ovarian cancer in Estonia.

|Jan 21, 2026
Nationwide Study of Pediatric Drug-Resistant Epilepsy in Estonia: Lower Incidence and Insights into Etiology.

Stella Lilles, Klari Heidmets, Kaisa Teele Oja

|Apr 14, 2025
Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores.

Peeter Padrik, Neeme Tõnisson, Tone Hovda

|Apr 14, 2025
Genotype/Phenotype Relationship: Lessons From 137 Patients With PMM2-CDG.

Sander Pajusalu, Mari-Anne Vals, Mercedes Serrano

|Feb 04, 2024
Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy.

Sandra Donkervoort, Payam Mohassel, Melanie O'Leary

Pageof 4

Frequent Collaborators

15 joint publications

Katrin Õunap

4 joint publications

Laura Roht

3 joint publications

Monica H Wojcik

2 joint publications

Tiina Kahre